Packaging- Single-Dose Vial

Strength- 100 mg/5 ml & 400 mg/20 ml

Get an Enquiry


Daratumumab is an anti-cancer medication indicated for the treatment of:

Multiple Myeloma: In the patient who had received at least three prior therapies.

Newly Diagnosed Multiple Myeloma: Patients who are not able for autologous stem cell transplant may receive Daratumumab with a combination of the melphalan, bortezomib, and prednisone.

As a Monotherapy: Darazalex can be also taken by the patients with relapsed and refractory multiple myeloma.

Dosage and Side Effects

You should receive Daratumumab Injection as an infusion into your vein (Intravenously) by your healthcare provider.

  • Some most common adverse reactions include fever, tiredness, nausea, diarrhea, shortness of breath, feeling week, decreased appetite, cold-like symptoms, chills, and dizziness.
  • Also, severe side effects of Darzalex (Daratumumab) include infusion reactions, vomiting, lung infection, decreased blood cell count and swollen hands, ankles, and feet.

Warning and Precautions

  • In the case of Neutropenia should be monitored complete blood count periodically during the treatment.
  • Patients with previously Hepatitis B infection should talk with your healthcare provider. It can active the Hepatitis B infection again.
  • Darzalex contraindicated for the patient with a history of severe hypersensitivity.
  • Patients with thrombocytopenia should be monitored closely as well as monitor complete blood cells count while on Daratumumab.
  • Patients with Infusion reactions should interrupt the infusion of Daratumumab (Darzalex).


What are the inactive ingredients of Darzalex(Daratumumab)?

Mannitol, Sodium Acetate Tri-hydrate, Glacial Acetic Acid, Sodium Chloride, Polysorbate 20 and Water for Injection are some Inactive Ingredients.

Is Daratumumab immunotherapy or chemo?

Daratumumab is an immunoglobulin G1 kappa (IgG1κ) human monoclonal antibody. Therefore it is not a chemotherapy medicine. It is a targeted therapy also known as immunotherapy.

Is Daratumumab FDA approved?

Yes. The FDA must first approve generic drugs before they are marketed. The FDA requires that generic drugs must be as high in quality, and as strong, pure and stable as brand name drugs.

How is Daratumumab given?

Daratumumab is either given in combination with other drugs or alone to treat multiple myeloma. Healthcare professionals give this medicine through intravenous infusion according to the prescribed dosage to the patients.

What to do in case of Daratumumab overdose?

There is no data or case study on the overdose of Daratumumab, yet if one takes the overdose of Daratumumab, contact the doctor for worsening signs and symptoms and keep the patient under observation.

From where i can buy Daratumumab 440 mg?

  • You can buy daratumumab from any authorized whole seller after getting prescription from a qualified doctor. It is always better to check the credential of the whole seller/supplier/exporter before buying the product.
  • The buyer should check the existing law in their home country before importing the product.